Influence of CYP2C9 and VKORC1 polymorphisms on the time required to reach the therapeutic INR

Florentina C. Militaru; Sorin Cri?an; ?tefan C. Vesa; Adrian Trifa; Valentin Militaru; Anca D. Buzoianu

首页> 外文期刊>Human Veterinary Medicine-International Journal of the Bioflux Society >Influence of CYP2C9 and VKORC1 polymorphisms on the time required to reach the therapeutic INR

【24h】

Influence of CYP2C9 and VKORC1 polymorphisms on the time required to reach the therapeutic INR

机译：CYP2C9和VKORC1多态性对达到治疗性INR所需时间的影响

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AcademicJournalsDatabaseisauniversalindexofperiodicalliteraturecoveringbasicresearchfromallfieldsofknowledge,andisparticularlystronginmedicalresearch,humanitiesandsocialsciences.Full-textfrommostofthearticlesisavailable.AcademicJournalsDatabasecontainscompletebibliographiccitations,preciseindexing,andinformativeabstractsforpapersfromawiderangeofperiodicals.

机译：学术期刊数据库是从所有领域的知识中进行基础研究的定期文献通用索引，尤其是强力的医学研究，人文科学和社会科学。

著录项

来源
《Human Veterinary Medicine-International Journal of the Bioflux Society》 |2012年第3期|共页
作者
Florentina C. Militaru; Sorin Cri?an; ?tefan C. Vesa; Adrian Trifa; Valentin Militaru; Anca D. Buzoianu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类动物医学（兽医学）;
关键词

相似文献

外文文献
中文文献
专利

1. Polymorphisms of CYP2C9*2 , CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin [J] . Maria Mariana Barros Melo da Silveira, Leiliandry de Araújo Melo, Filipe Maia Ferreira Gomes, The Application of Clinical Genetics . 2019,第4期

机译：CYP2C9 * 2，CYP2C9 * 3和VKORC1基因多态性与华法林治疗房颤患者治疗时间的关系
2. Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 Genes and the Therapeutic Warfarin Dose in Brazilian Patients with Thrombosis: A Prospective Cohort Study [J] . de Oliveira Almeida Vanessa Cristina, Ribeiro Daniel Dias, Gomes Karina Braga, Molecular diagnosis & therapy . 2014,第6期

机译：CYP2C9，VKORC1，MDR1，APOE和UGT1A1基因多态性与华法林在巴西血栓形成患者中的治疗剂量：一项前瞻性队列研究
3. Influence of VKORC1 and CYP2C9 Polymorphisms on Daily Acenocoumarol Dose Requirement in South Indian Patients With Mechanical Heart Valves [J] . S. R. Kalpana, G. Bharath, C. N. Manjunath, Clinical and applied thrombosis/hemostasis : . 2017,第7期

机译：VKORC1和CYP2C9多态性对印度南部机械心脏瓣膜患者每日Acenocoumarol剂量需求的影响
4. BIOCHEMICAL ANALYSIS OF VKORC1 POLYMORPHISMS IN SOME IRANIAN WARFARIN RESISTANT PATIENTS [C] . F. Sadeghian, P. Ghadam, R. Sharifian the European Peptide Symposium . 2007

机译：一些伊朗华法林耐药患者的VKORC1多态性的生化分析
5. Cost-Effectiveness of Current Anticoagulation Care versus Genetic Testing of CYP2C9 and VKORC1 Prior to Long-Term Warfarin Anticoagulation Care: The Implementation of Discrete Event Simulation Model on the Natural History of Venous Thromboembolism. [D] . Teschemaker, Anna R. 2011

机译：当前抗凝治疗的成本效果与长期华法林抗凝治疗之前的CYP2C9和VKORC1遗传检测的关系：基于静脉血栓栓塞自然史的离散事件模拟模型的实现。
6. Polymorphisms of CYP2C9*2 CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin [O] . Maria Mariana Barros Melo da Silveira, Leiliandry de Araújo Melo, Filipe Maia Ferreira Gomes, 2019

机译：CYP2C9 * 2CYP2C9 * 3和VKORC1基因多态性与华法林治疗房颤患者治疗时间的相关性
7. Utjecaj kombinacije polimorfizma gena CYP2C9, VKORC1 i MDR1 na individualizaciju terapije varfarinom Influence of combination of CYP2C9, VKORC1 and MDR1 geneudpolymorphisms on individualization of warfarine therapy [O] . Makar-Aušperger Ksenija 2015

机译：CYp2C9，VKORC1和mDR1基因多态性对华法林治疗个体化的影响CYp2C9，VKORC1和mDR1基因组合的影响华法治疗个体化的多态性

Influence of CYP2C9 and VKORC1 polymorphisms on the time required to reach the therapeutic INR

摘要

著录项

相似文献

相关主题

期刊订阅